ID   MA2B1_HUMAN             Reviewed;        1011 AA.
AC   O00754; G5E928; O15330; Q16680; Q93094; Q9BW13;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Lysosomal alpha-mannosidase;
DE            Short=Laman;
DE            EC=3.2.1.24;
DE   AltName: Full=Lysosomal acid alpha-mannosidase;
DE   AltName: Full=Mannosidase alpha class 2B member 1;
DE   AltName: Full=Mannosidase alpha-B;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase A peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase B peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase C peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase D peptide;
DE   Contains:
DE     RecName: Full=Lysosomal alpha-mannosidase E peptide;
DE   Flags: Precursor;
GN   Name=MAN2B1; Synonyms=LAMAN, MANB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8166692; DOI=10.1006/bbrc.1994.1440;
RA   Nebes V.L., Schmidt M.C.;
RT   "Human lysosomal alpha-mannosidase: isolation and nucleotide sequence
RT   of the full-length cDNA.";
RL   Biochem. Biophys. Res. Commun. 200:239-245(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANT MANSA LEU-72.
RC   TISSUE=Lung, and Skin;
RX   PubMed=9158146; DOI=10.1093/hmg/6.5.717;
RA   Nilssen O., Berg T., Riise H.M.F., Ramachandran U., Evjen G.,
RA   Hansen G.M., Malm D., Tranebjaerg L., Tollersrud O.-K.;
RT   "Alpha-mannosidosis: functional cloning of the lysosomal alpha-
RT   mannosidase cDNA and identification of a mutation in two affected
RT   siblings.";
RL   Hum. Mol. Genet. 6:717-726(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=9192839; DOI=10.1006/geno.1997.4668;
RA   Riise H.M.F., Berg T., Nilssen O., Romeo G., Tollersrud O.-K.,
RA   Ceccherini I.;
RT   "Genomic structure of the human lysosomal alpha-mannosidase gene
RT   (MANB).";
RL   Genomics 42:200-207(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-1010 (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=8910458; DOI=10.1074/jbc.271.45.28348;
RA   Liao Y.-F., Lal A., Moremen K.W.;
RT   "Cloning, expression, purification, and characterization of the human
RT   broad specificity lysosomal acid alpha-mannosidase.";
RL   J. Biol. Chem. 271:28348-28358(1996).
RN   [8]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=7832746; DOI=10.1042/bj3050363;
RA   Emiliani C., Martino S., Stirling J.L., Maras B., Orlacchio A.;
RT   "Partial sequence of the purified protein confirms the identity of
RT   cDNA coding for human lysosomal alpha-mannosidase B.";
RL   Biochem. J. 305:363-366(1995).
RN   [9]
RP   GLYCOSYLATION AT ASN-930.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-367 AND ASN-766.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANTS MANSA LEU-72; ARG-356 AND TRP-750.
RX   PubMed=9758606; DOI=10.1086/302048;
RA   Gotoda Y., Wakamatsu N., Kawai H., Nishida Y., Matsumoto T.;
RT   "Missense and nonsense mutations in the lysosomal alpha-mannosidase
RT   gene (MANB) in severe and mild forms of alpha-mannosidosis.";
RL   Am. J. Hum. Genet. 63:1015-1024(1998).
RN   [15]
RP   VARIANTS MANSA PRO-355; LYS-402; ARG-714 AND PRO-809, AND VARIANTS
RP   VAL-278; ILE-312; GLN-337 AND SER-413.
RX   PubMed=9915946; DOI=10.1086/302183;
RA   Berg T., Riise H.M.F., Hansen G.M., Malm D., Tranebjaerg L.,
RA   Tollersrud O.-K., Nilssen O.;
RT   "Spectrum of mutations in alpha-mannosidosis.";
RL   Am. J. Hum. Genet. 64:77-88(1999).
RN   [16]
RP   VARIANT MANSA TYR-453.
RX   PubMed=12718372;
RA   Oelmez A., Nilssen O., Coskun T., Klenow H.;
RT   "Alpha-mannosidosis and mutational analysis in a Turkish patient.";
RL   Turk. J. Pediatr. 45:46-50(2003).
RN   [17]
RP   VARIANTS MANSA LEU-200 AND ASP-801, AND CHARACTERIZATION OF VARIANTS
RP   MANSA LEU-200 AND ASP-801.
RX   PubMed=15712269; DOI=10.1002/humu.9310;
RA   Sbaragli M., Bibi L., Pittis M.G., Balducci C., Heikinheimo P.,
RA   Ricci R., Antuzzi D., Parini R., Spaccini L., Bembi B., Beccari T.;
RT   "Identification and characterization of five novel MAN2B1 mutations in
RT   Italian patients with alpha-mannosidosis.";
RL   Hum. Mutat. 25:320-320(2005).
RN   [18]
RP   VARIANTS MANSA PHE-55; GLU-74; PRO-95; HIS-99; ASN-159; ARG-197;
RP   ASN-200; LEU-200; PRO-202; TRP-229; LEU-263; LEU-318; 339-VAL--GLN-342
RP   DEL; PRO-352; LEU-379; CYS-390; LYS-402; VAL-420; TYR-445; CYS-451;
RP   TYR-453; PHE-453; GLU-457; SER-501; PRO-565; ARG-745; ARG-800;
RP   TRP-800; HIS-ARG-815 INS; ARG-891; PRO-892; CYS-916; HIS-916; PRO-950;
RP   ARG-956 AND SER-1000, VARIANTS LEU-248; VAL-278; SER-282; ILE-312;
RP   GLN-337; SER-413; SER-481 AND LEU-669, AND CHARACTERIZATION OF
RP   VARIANTS MANSA PHE-55; GLU-74; PRO-95; HIS-99; ASN-159; ARG-197;
RP   ASN-200; LEU-200; PRO-202; TRP-229; LEU-263; LEU-318; PRO-352;
RP   LEU-379; CYS-390; LYS-402; VAL-420; TYR-445; CYS-451; TYR-453;
RP   PHE-453; GLU-457; SER-501; PRO-565; ARG-745; ARG-800; TRP-800;
RP   HIS-ARG-815 INS; ARG-891; PRO-892; CYS-916; HIS-916; PRO-950; ARG-956
RP   AND SER-1000.
RX   PubMed=22161967; DOI=10.1002/humu.22005;
RA   Riise Stensland H.M., Klenow H.B., Van Nguyen L., Hansen G.M.,
RA   Malm D., Nilssen O.;
RT   "Identification of 83 novel alpha-mannosidosis-associated sequence
RT   variants: functional analysis of MAN2B1 missense mutations.";
RL   Hum. Mutat. 33:511-520(2012).
CC   -!- FUNCTION: Necessary for the catabolism of N-linked carbohydrates
CC       released during glycoprotein turnover. Cleaves all known types of
CC       alpha-mannosidic linkages.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of terminal, non-reducing alpha-D-
CC       mannose residues in alpha-D-mannosides.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00754-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00754-2; Sequence=VSP_047391;
CC         Note=Gene prediction based on EST data.;
CC   -!- PTM: First processed into 3 peptides of 70 kDa, 42 kDa (D) and
CC       13/15 kDa (E). The 70 kDa peptide is further processed into three
CC       peptides (A, B and C). The A, B and C peptides are disulfide-
CC       linked.
CC   -!- PTM: Heavily glycosylated. {ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A
CC       lysosomal storage disease characterized by accumulation of
CC       unbranched oligosaccharide chains. This accumulation is expressed
CC       histologically as cytoplasmic vacuolation predominantly in the CNS
CC       and parenchymatous organs. Depending on the clinical findings at
CC       the age of onset, a severe infantile (type I) and a mild juvenile
CC       (type II) form of alpha-mannosidosis are recognized. There is
CC       considerable variation in the clinical expression with mental
CC       retardation, recurrent infections, impaired hearing and Hurler-
CC       like skeletal changes being the most consistent abnormalities.
CC       {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269,
CC       ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146,
CC       ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 38 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB03816.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC50812.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mendelian genes mannosidase, alpha, class 2B,
CC       member 1 (MAN2B1); Note=Leiden Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/MAN2B1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U05572; AAB03816.1; ALT_INIT; mRNA.
DR   EMBL; U60266; AAC34130.1; -; mRNA.
DR   EMBL; U60899; AAC51362.1; -; Genomic_DNA.
DR   EMBL; U60885; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60886; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60887; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60888; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60889; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60890; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60891; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60892; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60893; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60894; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60895; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60896; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60897; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; U60898; AAC51362.1; JOINED; Genomic_DNA.
DR   EMBL; AC010422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84279.1; -; Genomic_DNA.
DR   EMBL; BC000736; AAH00736.1; -; mRNA.
DR   EMBL; U68567; AAC50812.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32919.1; -. [O00754-1]
DR   CCDS; CCDS54224.1; -. [O00754-2]
DR   RefSeq; NP_000519.2; NM_000528.3. [O00754-1]
DR   RefSeq; NP_001166969.1; NM_001173498.1. [O00754-2]
DR   UniGene; Hs.356769; -.
DR   UniGene; Hs.657204; -.
DR   ProteinModelPortal; O00754; -.
DR   SMR; O00754; -.
DR   BioGrid; 110298; 16.
DR   IntAct; O00754; 2.
DR   MINT; MINT-253662; -.
DR   STRING; 9606.ENSP00000395473; -.
DR   BindingDB; O00754; -.
DR   ChEMBL; CHEMBL4059; -.
DR   CAZy; GH38; Glycoside Hydrolase Family 38.
DR   iPTMnet; O00754; -.
DR   PhosphoSitePlus; O00754; -.
DR   UniCarbKB; O00754; -.
DR   BioMuta; MAN2B1; -.
DR   EPD; O00754; -.
DR   MaxQB; O00754; -.
DR   PaxDb; O00754; -.
DR   PeptideAtlas; O00754; -.
DR   PRIDE; O00754; -.
DR   DNASU; 4125; -.
DR   Ensembl; ENST00000221363; ENSP00000221363; ENSG00000104774. [O00754-2]
DR   Ensembl; ENST00000456935; ENSP00000395473; ENSG00000104774. [O00754-1]
DR   GeneID; 4125; -.
DR   KEGG; hsa:4125; -.
DR   UCSC; uc002mub.3; human. [O00754-1]
DR   CTD; 4125; -.
DR   DisGeNET; 4125; -.
DR   GeneCards; MAN2B1; -.
DR   GeneReviews; MAN2B1; -.
DR   HGNC; HGNC:6826; MAN2B1.
DR   HPA; HPA041530; -.
DR   HPA; HPA053404; -.
DR   MalaCards; MAN2B1; -.
DR   MIM; 248500; phenotype.
DR   MIM; 609458; gene.
DR   neXtProt; NX_O00754; -.
DR   OpenTargets; ENSG00000104774; -.
DR   Orphanet; 309288; Alpha-mannosidosis, adult form.
DR   Orphanet; 309282; Alpha-mannosidosis, infantile form.
DR   PharmGKB; PA30575; -.
DR   eggNOG; KOG1959; Eukaryota.
DR   eggNOG; ENOG410XQMZ; LUCA.
DR   GeneTree; ENSGT00510000046304; -.
DR   HOGENOM; HOG000007676; -.
DR   HOVERGEN; HBG052391; -.
DR   InParanoid; O00754; -.
DR   KO; K12311; -.
DR   OMA; PPADEKI; -.
DR   OrthoDB; EOG091G02IS; -.
DR   PhylomeDB; O00754; -.
DR   TreeFam; TF313840; -.
DR   BRENDA; 3.2.1.24; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8853383; Lysosomal oligosaccharide catabolism.
DR   ChiTaRS; MAN2B1; human.
DR   GenomeRNAi; 4125; -.
DR   PRO; PR:O00754; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104774; -.
DR   CleanEx; HS_MAN2B1; -.
DR   ExpressionAtlas; O00754; baseline and differential.
DR   Genevisible; O00754; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0004559; F:alpha-mannosidase activity; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006464; P:cellular protein modification process; IDA:UniProtKB.
DR   GO; GO:0006013; P:mannose metabolic process; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0009313; P:oligosaccharide catabolic process; TAS:Reactome.
DR   GO; GO:0006517; P:protein deglycosylation; TAS:ProtInc.
DR   Gene3D; 1.20.1270.50; -; 2.
DR   Gene3D; 3.20.110.10; -; 1.
DR   InterPro; IPR011013; Gal_mutarotase_SF_dom.
DR   InterPro; IPR011330; Glyco_hydro/deAcase_b/a-brl.
DR   InterPro; IPR027291; Glyco_hydro_38/57_N.
DR   InterPro; IPR011682; Glyco_hydro_38_C.
DR   InterPro; IPR015341; Glyco_hydro_38_cen.
DR   InterPro; IPR000602; Glyco_hydro_38_N.
DR   InterPro; IPR028995; Glyco_hydro_57/38_cen.
DR   Pfam; PF09261; Alpha-mann_mid; 1.
DR   Pfam; PF01074; Glyco_hydro_38; 1.
DR   Pfam; PF07748; Glyco_hydro_38C; 1.
DR   SMART; SM00872; Alpha-mann_mid; 1.
DR   SUPFAM; SSF74650; SSF74650; 1.
DR   SUPFAM; SSF88688; SSF88688; 1.
DR   SUPFAM; SSF88713; SSF88713; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Glycosidase;
KW   Hydrolase; Lysosome; Metal-binding; Polymorphism; Reference proteome;
KW   Signal; Zinc; Zymogen.
FT   SIGNAL        1     49
FT   CHAIN        50   1011       Lysosomal alpha-mannosidase.
FT                                /FTId=PRO_0000012069.
FT   CHAIN        50    345       Lysosomal alpha-mannosidase A peptide.
FT                                /FTId=PRO_0000012070.
FT   CHAIN       346    429       Lysosomal alpha-mannosidase B peptide.
FT                                /FTId=PRO_0000012071.
FT   CHAIN       430    601       Lysosomal alpha-mannosidase C peptide.
FT                                /FTId=PRO_0000012072.
FT   CHAIN       602    882       Lysosomal alpha-mannosidase D peptide.
FT                                /FTId=PRO_0000012073.
FT   CHAIN       883   1011       Lysosomal alpha-mannosidase E peptide.
FT                                /FTId=PRO_0000012074.
FT   ACT_SITE    196    196       Nucleophile. {ECO:0000250}.
FT   METAL        72     72       Zinc. {ECO:0000250}.
FT   METAL        74     74       Zinc. {ECO:0000250}.
FT   METAL       196    196       Zinc. {ECO:0000250}.
FT   METAL       446    446       Zinc. {ECO:0000250}.
FT   CARBOHYD    133    133       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    367    367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    497    497       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    645    645       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    651    651       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    692    692       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    766    766       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    832    832       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    930    930       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    989    989       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     55    358       {ECO:0000250}.
FT   DISULFID    268    273       {ECO:0000250}.
FT   DISULFID    412    472       {ECO:0000250}.
FT   DISULFID    493    501       {ECO:0000250}.
FT   VAR_SEQ     343    343       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_047391.
FT   VARIANT      55     55       C -> F (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621975).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068034.
FT   VARIANT      72     72       H -> L (in MANSA; type II;
FT                                dbSNP:rs387906261).
FT                                {ECO:0000269|PubMed:9158146,
FT                                ECO:0000269|PubMed:9758606}.
FT                                /FTId=VAR_003338.
FT   VARIANT      74     74       D -> E (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs746702002).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068035.
FT   VARIANT      95     95       A -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs754036398).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068036.
FT   VARIANT      99     99       Y -> H (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs794727484).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068037.
FT   VARIANT     159    159       D -> N (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621976).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068038.
FT   VARIANT     197    197       P -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621977).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068039.
FT   VARIANT     200    200       H -> L (in MANSA; no residual enzyme
FT                                activity; dbSNP:rs864621978).
FT                                {ECO:0000269|PubMed:15712269,
FT                                ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_026412.
FT   VARIANT     200    200       H -> N (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs772108001).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068040.
FT   VARIANT     202    202       R -> P (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621979).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068041.
FT   VARIANT     229    229       R -> W (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs763257568).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068042.
FT   VARIANT     248    248       P -> L (in dbSNP:rs117843968).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068043.
FT   VARIANT     250    250       A -> S (in dbSNP:rs3745650).
FT                                /FTId=VAR_049209.
FT   VARIANT     263    263       P -> L (in MANSA; results in less than
FT                                20% of wild-type enzyme activity).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068044.
FT   VARIANT     278    278       L -> V (in dbSNP:rs1054486).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003339.
FT   VARIANT     282    282       P -> S (in dbSNP:rs45576136).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068045.
FT   VARIANT     312    312       T -> I (in dbSNP:rs1054487).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003340.
FT   VARIANT     318    318       S -> L (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs774034389).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068046.
FT   VARIANT     337    337       R -> Q (in dbSNP:rs1133330).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003341.
FT   VARIANT     339    342       Missing (in MANSA).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068047.
FT   VARIANT     352    352       L -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621980).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068048.
FT   VARIANT     355    355       T -> P (in MANSA; dbSNP:rs864621992).
FT                                {ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003342.
FT   VARIANT     356    356       P -> R (in MANSA; type I;
FT                                dbSNP:rs121434333).
FT                                {ECO:0000269|PubMed:9758606}.
FT                                /FTId=VAR_003343.
FT   VARIANT     379    379       P -> L (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621981).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068049.
FT   VARIANT     390    390       G -> C (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621982).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068050.
FT   VARIANT     402    402       E -> K (in MANSA; unknown pathological
FT                                significance; dbSNP:rs370760999).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003344.
FT   VARIANT     413    413       N -> S (in dbSNP:rs35836657).
FT                                {ECO:0000269|PubMed:22161967,
FT                                ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003345.
FT   VARIANT     420    420       G -> V (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs772853856).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068051.
FT   VARIANT     445    445       H -> Y (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621983).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068052.
FT   VARIANT     451    451       G -> C (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs368899357).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068053.
FT   VARIANT     453    453       S -> F (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621984).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068054.
FT   VARIANT     453    453       S -> Y (in MANSA; dbSNP:rs864621984).
FT                                {ECO:0000269|PubMed:12718372,
FT                                ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_026413.
FT   VARIANT     457    457       V -> E (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs864621985).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068055.
FT   VARIANT     481    481       A -> S (in dbSNP:rs34544747).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_049210.
FT   VARIANT     501    501       C -> S (in MANSA; reduced enzyme
FT                                activity; dbSNP:rs747721968).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068056.
FT   VARIANT     565    565       L -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621986).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068057.
FT   VARIANT     669    669       P -> L (in dbSNP:rs75029862).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068058.
FT   VARIANT     714    714       W -> R (in MANSA; dbSNP:rs864621993).
FT                                {ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003346.
FT   VARIANT     745    745       T -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621987).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068059.
FT   VARIANT     750    750       R -> W (in MANSA; type II;
FT                                dbSNP:rs80338680).
FT                                {ECO:0000269|PubMed:9758606}.
FT                                /FTId=VAR_003347.
FT   VARIANT     800    800       G -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs398123456).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068060.
FT   VARIANT     800    800       G -> W (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs398123456).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068061.
FT   VARIANT     801    801       G -> D (in MANSA; no residual enzyme
FT                                activity; dbSNP:rs864621994).
FT                                {ECO:0000269|PubMed:15712269}.
FT                                /FTId=VAR_026414.
FT   VARIANT     809    809       L -> P (in MANSA; dbSNP:rs80338681).
FT                                {ECO:0000269|PubMed:9915946}.
FT                                /FTId=VAR_003348.
FT   VARIANT     815    815       R -> RHR (in MANSA; results in less than
FT                                20% of wild-type enzyme activity).
FT                                /FTId=VAR_068062.
FT   VARIANT     891    891       G -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621988).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068063.
FT   VARIANT     892    892       L -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621989).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068064.
FT   VARIANT     916    916       R -> C (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621990).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068065.
FT   VARIANT     916    916       R -> H (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs758765126).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068066.
FT   VARIANT     950    950       R -> P (in MANSA; results in less than
FT                                20% of wild-type enzyme activity).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068067.
FT   VARIANT     956    956       L -> R (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs768233248).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068068.
FT   VARIANT    1000   1000       F -> S (in MANSA; results in less than
FT                                20% of wild-type enzyme activity;
FT                                dbSNP:rs864621991).
FT                                {ECO:0000269|PubMed:22161967}.
FT                                /FTId=VAR_068069.
FT   CONFLICT      3      3       Missing (in Ref. 3; AAC51362).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       D -> V (in Ref. 2; AAC34130).
FT                                {ECO:0000305}.
FT   CONFLICT    384    384       P -> H (in Ref. 7; AAC50812).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1011 AA;  113744 MW;  E11C77C19D8BD88C CRC64;
     MGAYARASGV CARGCLDSAG PWTMSRALRP PLPPLCFFLL LLAAAGARAG GYETCPTVQP
     NMLNVHLLPH THDDVGWLKT VDQYFYGIKN DIQHAGVQYI LDSVISALLA DPTRRFIYVE
     IAFFSRWWHQ QTNATQEVVR DLVRQGRLEF ANGGWVMNDE AATHYGAIVD QMTLGLRFLE
     DTFGNDGRPR VAWHIDPFGH SREQASLFAQ MGFDGFFFGR LDYQDKWVRM QKLEMEQVWR
     ASTSLKPPTA DLFTGVLPNG YNPPRNLCWD VLCVDQPLVE DPRSPEYNAK ELVDYFLNVA
     TAQGRYYRTN HTVMTMGSDF QYENANMWFK NLDKLIRLVN AQQAKGSSVH VLYSTPACYL
     WELNKANLTW SVKHDDFFPY ADGPHQFWTG YFSSRPALKR YERLSYNFLQ VCNQLEALVG
     LAANVGPYGS GDSAPLNEAM AVLQHHDAVS GTSRQHVAND YARQLAAGWG PCEVLLSNAL
     ARLRGFKDHF TFCQQLNISI CPLSQTAARF QVIVYNPLGR KVNWMVRLPV SEGVFVVKDP
     NGRTVPSDVV IFPSSDSQAH PPELLFSASL PALGFSTYSV AQVPRWKPQA RAPQPIPRRS
     WSPALTIENE HIRATFDPDT GLLMEIMNMN QQLLLPVRQT FFWYNASIGD NESDQASGAY
     IFRPNQQKPL PVSRWAQIHL VKTPLVQEVH QNFSAWCSQV VRLYPGQRHL ELEWSVGPIP
     VGDTWGKEVI SRFDTPLETK GRFYTDSNGR EILERRRDYR PTWKLNQTEP VAGNYYPVNT
     RIYITDGNMQ LTVLTDRSQG GSSLRDGSLE LMVHRRLLKD DGRGVSEPLM ENGSGAWVRG
     RHLVLLDTAQ AAAAGHRLLA EQEVLAPQVV LAPGGGAAYN LGAPPRTQFS GLRRDLPPSV
     HLLTLASWGP EMVLLRLEHQ FAVGEDSGRN LSAPVTLNLR DLFSTFTITR LQETTLVANQ
     LREAASRLKW TTNTGPTPHQ TPYQLDPANI TLEPMEIRTF LASVQWKEVD G
//
